For the Inventor, By the Inventor

Enter assignee name

Little Island, Co. Cork, Ireland

Janssen R&d Ireland

USPTO Granted Patents = 45

CIPO Patents = 13

EPO Patents = 37

Trademarks = 4

Forward Citations = 132

Loading Chart...

Loading Chart...

104 inventors (with patents filed for the assignee):

Pierre Jean-Marie Bernard Raboisson (17 out of 178 patents)

Abdellah Tahri (11 out of 61 patents)

Herman Augustinus De Kock (10 out of 36 patents)

4. Tim Hugo Maria Jonckers (9 out of 77 patents)

5. Sandrine Marie Helene Vendeville (9 out of 41 patents)

6. Lili Hu (8 out of 37 patents)

7. Bengt Bertil Samuelsson (7 out of 24 patents)

8. Åsa Annica Kristina Rosenquist (7 out of 18 patents)

9. Jerôme Emile Georges Guillemont (6 out of 27 patents)

10. Kenneth Simmen (6 out of 26 patents)

11. Karl Magnus Nilsson (6 out of 18 patents)

12. David Craig McGowan (5 out of 61 patents)

13. Stefaan Julien Last (5 out of 37 patents)

14. Ludwig Paul Cooymans (4 out of 25 patents)

15. Lieven Elvire Colette Baert (4 out of 17 patents)

Core Competencies:

Polyinosinic-Polycytidylic Acid

Hepatitis C Virus Inhibitors

Respiratory Syncytial Virus

Macrocyclic Compounds

Antiviral Agents

Pyrimidine Derivatives

HIV Protease Inhibitors

Antibacterial Compounds

Sustained Release Formulations

Imidazopyridines

Phenyl Ethynyl Derivatives

Co-Crystals

45 patents: Sort by Forward Citations

1. 9682096 - Polyinosinic-polycytidylic acid (poly (I:C)) formulations for the treatment of upper respiratory tract infections (2017-06-20),

2. 9045463 - Phenyl ethynyl derivatives as hepatitis C virus inhibitors (2015-06-02),

3. 9040562 - Macrocyclic inhibitors of hepatitis C virus (2015-05-26),

4. 9028876 - Rate-controlled particles (2015-05-12),

5. 9023808 - Macrocyclic inhibitors of hepatitis C virus (2015-05-05),

6. 9012634 - Antibacterial piperidinyl substituted 3,4-dihydro-1H-[1,8]naphthyridinones (2015-04-21),

7. 9006243 - HIV inhibiting 6-substituted pyrimidines (2015-04-14),

8. 8946248 - HIV inhibiting 5-substituted pyrimidines (2015-02-03),

9. 8937080 - Pyrimidine substituted macrocyclic HCV inhibitors (2015-01-20),

10. 8933089 - HIV inhibiting 5-amido substituted pyrimidines (2015-01-13),

11. 8927720 - Azabenzimidazoles as respiratory syncytial virus antiviral agents (2015-01-06),

12. 8921560 - Indoles as respiratory syncytial virus antiviral agents (2014-12-30),

13. 8921355 - Macrocyclic indole derivatives useful as hepatitis C virus inhibitors (2014-12-30),

14. 8916575 - Quinazoline derivatives for the treatment of viral infections and further diseases (2014-12-23),

15. 8906923 - Antibacterial cyclopenta[c]pyrrole substituted 3,4-dihydro-1H-[1,8]naphthyridinones (2014-12-09),

Janssen R&D Ireland is a pharmaceutical research and development company located in Ireland. It is a part of Janssen Pharmaceutical Companies, which is a subsidiary of Johnson & Johnson. Janssen R&D Ireland focuses on the discovery and development of new drugs and therapies in various therapeutic areas. Their research efforts aim to improve the lives of patients worldwide by providing innovative healthcare solutions.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 16 2025

45 Patents

#1 in Little Island, Co. Cork

#64 in Ireland

#14,976 in the World

Little Island, Co. Cork, Ireland

Janssen R&d Ireland

Forward Citations = 132

104 inventors:

Pierre Jean-Marie Bernard Raboisson (17 out of 178 patents)

Abdellah Tahri (11 out of 61 patents)

Herman Augustinus De Kock (10 out of 36 patents)

4. Tim Hugo Maria Jonckers (9 out of 77 patents)

5. Sandrine Marie Helene Vendeville (9 out of 41 patents)

Please report any incorrect information to support@idiyas.com

Loading…